Charlie is a senior counsel in our Cambridge office specialising in the commercialisation of intellectual property in the life sciences and technology sectors.
Charlie specialises in the commercialisation of intellectual property in the life sciences and technology sectors. He works with clients on key strategic transactions throughout their lifecycle. This ranges from advising start-ups on foundational licensing deals and R&D collaborations through to working with established multinational companies on distribution, manufacturing and other commercial arrangements. He also advises on the IP, commercial and regulatory aspects of VC investment and M&A.
With over a decade of experience in the Cambridge ecosystem, Charlie has a particular focus on leveraging his later-stage experience when advising early-stage clients and regularly delivers training to new founders taking part in life sciences incubators and accelerators throughout the UK.
Leading associate
Corporate and commercial - Cambridge
Intellectual Property
par Colin McCall et Charlie Adams
Advising on Draig Therapeutics' US$140 million series A financing
par plusieurs auteurs
Antiverse and Nxera Pharma enter collaboration to design novel GPCR-targeted antibody therapeutics
par Colin McCall et Charlie Adams
par Bridget Winters
par Dr. Christian Frank, Licencié en droit (Paris II / Panthéon-Assas)
par plusieurs auteurs
par plusieurs auteurs
par Giles Crown
par Charlotte Peach et Giles Crown
par plusieurs auteurs
par plusieurs auteurs
par Laura Coucke et Adam Lybaert